PubMed:32292227 / 0-8
[Controversy regarding ACE inhibitors / ARBs in Covid-19].
Controversias sobre el tratamiento con IECA/ARA-II y Covid-19.
|
[Controversy regarding ACE inhibitors / ARBs in Covid-19].
Controversias sobre el tratamiento con IECA/ARA-II y Covid-19.
|